Advanced renal cell carcinoma: immunotherapy and tyrosine kinase inhibitor effective in the long term

Advanced renal cell carcinoma: immunotherapy and tyrosine kinase inhibitor effective in the long term

0 Comments

Chicago – First-generation angiogenic tyrosine kinase inhibitors have made significant progress in the treatment of advanced renal cell carcinoma for the first time. With immune checkpoint inhibitors in combination with next-generation angiogenesis inhibitors,… [weiter lesen]

#Advanced #renal #cell #carcinoma #immunotherapy #tyrosine #kinase #inhibitor #effective #long #term

Leave a Reply

Related Posts